Accepted Manuscript Protective immunity of grass carp immunized with DNA vaccine against Aeromonas hydrophila by using carbon nanotubes as a carrier molecule Lei Liu, Yu-Xin Gong, Guang-Lu Liu, Bin Zhu, Gao-Xue Wang PII:
S1050-4648(16)30386-2
DOI:
10.1016/j.fsi.2016.06.026
Reference:
YFSIM 4026
To appear in:
Fish and Shellfish Immunology
Received Date: 8 March 2016 Revised Date:
18 June 2016
Accepted Date: 21 June 2016
Please cite this article as: Liu L, Gong Y-X, Liu G-L, Zhu B, Wang G-X, Protective immunity of grass carp immunized with DNA vaccine against Aeromonas hydrophila by using carbon nanotubes as a carrier molecule, Fish and Shellfish Immunology (2016), doi: 10.1016/j.fsi.2016.06.026. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT 1
Protective immunity of grass carp immunized with DNA vaccine against Aeromonas hydrophila by
2
using carbon nanotubes as a carrier molecule
3
Lei Liua, Yu-Xin Gongb, Guang-Lu Liuc, Bin Zhua, Gao-Xue Wanga,*
a
College of Animal Science and Technology, Northwest A&F University, Xinong Road 22nd, Yangling,
6
Shaanxi 712100, China b
7
College of Veterinary Medicine, Northwest A&F University, Xinong Road 22nd, Yangling, Shaanxi
8
712100, China c
M AN U
9
SC
5
RI PT
4
College of Science, Northwest A&F University, Xinong Road 22nd, Yangling, Shaanxi 712100, China
10
* Corresponding author at: Northwest A&F University, Xinong Road 22nd, Yangling, Shaanxi 712100,
12
China. Tel./fax: +86 29 87092102.
TE D
11
13 14
EP
E-mail addresses:
[email protected] (Gao-Xue Wang)
Keywords: Single-walled carbon nanotubes; Aeromonas hydrophila; DNA vaccine; immunological
16
activity
17 18
AC C
15
With the capture fishing industry declined and wild stocks diminished, the aquaculture industry has
19
become an important source of food fish [1]. However, microbial pathologies are gradually primary
20
constraints factors to hinder desirable production output. One of the major bacterial diseases is caused by
21
a Gram-negative bacterium Aeromonas hydrophila which can cause serious damage in many animals [2],
ACCEPTED MANUSCRIPT especially fish [3,4], and is also harmful to human [5]. Generally, farmers use a wide range of antibiotics
23
or chemicals to control A. hydrophila infection [6]. However, these treatments may be detrimental to
24
environment and human health [7], since they pose negative such as antibiotic resistance in environment
25
and fish [8]. Therefore, vaccines have been developed as a sustainable alternative against A. hydrophila.
26
For example, some functional or structural proteins of A. hydrophila in recombinant form have been
27
evaluated for vaccine candidates [9-13], and attempts were also made to use recombinant A. hydrophila
28
vaccine via intramuscular injection to control the bacterial spread [11,14]. Currently, one of the most
29
promising vaccine preparations against fish diseases is the DNA vaccine (delivered intramuscularly)
30
consisting of naked plasmid DNA that will result in gene expression of pathogenic proteins in the muscle
31
tissue of the vaccinated fish [15]. Although these methods have been developed for many years, there are
32
still a number of limitations, such as stress on the fish, labor costs, time required and safety issues [16].
33
Furthermore, intramuscular injection of naked DNA vaccine generally induces few and transient immune
34
protection in fish [17]. To be more effective, DNA vaccines required effective carriers to overcome these
35
obstacles.
EP
TE D
M AN U
SC
RI PT
22
In the field of carrier systems, carbon nanotubes (CNTs) are potentially useful in their development
37
for transporting and translocating bioactive molecules [18], because they can rapidly enter into
38
antigen-presenting cells and make them especially useful as carriers of antigens/DNA [19-21]. More
39
importantly, a study was found that CNTs could enhance the expression of β-galactosidase marker gene
40
5~10 times higher levels than the plasmid DNA delivered alone [22]. Recently, a novel functionalized,
41
single-walled carbon nanotubes (SWCNTs) as a vector for recombinant vaccines were found. They can
42
produce specific antibodies to resist A. hydrophila or grass carp reovirus (GCRV) infection effectively
AC C
36
ACCEPTED MANUSCRIPT 43
[23,24]. Hence, the CNTs as a vaccine carrier could be potentially used to break through the cell barrier,
44
improve vaccine and induce a protective immune response. In this study, CNTs-aerA (a virulence factor that has hemolytic and cytolytic properties) vaccine was
46
prepared to enhance the efficacy of an aerA DNA vaccine against A. hydrophila in grass carp. We
47
evaluated the immune efficacy of CNTs-aerA DNA vaccine in vaccinating fish after intramuscular
48
injection. This study will provide a further information for future work on a wide range of CNTs-DNA
49
vaccine delivery systems in fish.
SC
RI PT
45
Grass carp with the total length and body weight of 3.0 ± 0.5 cm and 1.0 ± 0.1 g (mean values ± SD)
51
were kindly provided by the Xinmin Aquatic Breeding Center (Heyang, Shaanxi, China) and acclimatized
52
in the laboratory for two weeks before experimental manipulation. Fish were reared daily with a diet of
53
commercial dry pellets (Tianlong Feed Company, China) and held in 300 L aquaria at 28°C aerated fresh
54
water under laboratory conditions for two weeks, in which approximately 25% of the water was replaced
55
daily. According to the study of Vazquez-Juarez et al. [25], a PCR technique was used to confirm free
56
from A. hydrophila in fish. All protocols strictly adhered to the guide for care and use of laboratory
57
animals, and were approved by Northwest A&F University animal protection committee.
TE D
EP
A. hydrophila strain XS91-4-1 used in this experiment was preserved in our laboratory with 20%
AC C
58
M AN U
50
59
glycerol at -80°C. During the experimental period, A. hydrophila was inoculated into liquid LB medium
60
and grown overnight with constant shaking. Additionally, Escherichia coli DH5α (CWBIO, Beijing,
61
China) was also cultured in LB medium.
62 63
Cloning of aerA gene of A. hydrophila strain XS91-4-1 were performed according to our previous study
[24].
Two
oligonucleotide
primers
(F:
5'-GCAGAGCCCGTCTATCCAGA-3';
R:
ACCEPTED MANUSCRIPT 5'-TCACTCCAGCCTCAGGCCTTG-3') consists of Xho I and BamH I restriction enzyme sites,
65
respectively. After aerA gene were ligated with pMD19T vector (Takara, Dalian, China), transformed into
66
competent E. coli DH5α cells (CWBIO, Beijing, China) and sequenced by Sangon Biological Company
67
(Shanghai, China), the aerA gene excised from pMD19T-aerA by digestion with Xho I/BamH I restricion
68
enzyme (Takara, Dalian, China) was inserted into the pEGFP (Invitrogen, Carlsbad, CA, USA) to
69
generate pEGFP-aerA. A recombinant plasmid pEGFP-aerA containing the capsid open reading frame
70
was transformed into E. coli DH5a cells (CWBIO, Beijing, China) and the recombinant constructs were
71
sequenced by Sangon Biological Company (Shanghai, China). The positive clone was grown in LB broth
72
with ampicillin and incubated at 37
73
with the Endo-free Plasmid Mini Kit (Omega, USA) following the manufacturer's instructions and the
74
concentration was measured by the NanoDrop spectrophotometer (ND-1000, NanoDrop Technologies
75
Inc., Wilmington, DE) and conserved at -20
M AN U
SC
RI PT
64
overnight with shaking. Recombinant plasmid DNA was isolated
TE D
.
The raw SWCNTs were purchased from Chengdu Organic Chemicals Co., Ltd. Chinese Academy of
77
Sciences (Chengdu, China). Preparation of SWCNTs-pEGFP-aerA vaccine was performed as described
78
previously [23].
For vaccination experiments, healthy grass carp were distributed randomly into eight groups
AC C
79
EP
76
80
(containing six treatment groups and two control groups, 80 fish per group). The experimental fish were
81
injected intramuscularly with 0.1 mL pEGFP-aerA/SWCNTs-pEGFP-aerA (dissolve in PBS, pH = 7.4) in
82
three different doses (1, 5 and 10 µg) in the right, dorsal, epaxial muscle in front of the dorsal fin after
83
being anaesthetized with 20.0 g/m3 MS-222 [6]. The control groups were injected intramuscularly with 10
84
µg of pEGFP diluted in 0.1 mL PBS or 0.1 mL of PBS alone. Subsequently, control and vaccinated
ACCEPTED MANUSCRIPT 85
groups were transferred to different tanks during the whole immunization period (6 weeks). Antiserum preparation and measurement of anti-aerA antibody responses were made by
87
enzyme-linked immunosorbent assay (ELISA) according to the previous study [26], and rabbit sera
88
anti-IgM was prepared following the method of Ding et al. [27]. For analyses of the presence of specific,
89
neutralizing antibodies, vaccinated and control fish were sampled weekly until 6 weeks for antibody
90
determination. At each time points, five samples from each control and vaccinated groups were pooled
91
and prepared according the previous method [24]. Rabbit anti-IgM polyclonal antibody was used as
92
primary antibody, and HRP-conjugated goat anti-rabbit IgG (CWBIO, Beijing, China) was used as
93
secondary antibody. The primary and secondary antibodies were diluted 1:1000 immediately before use
94
with PBS containing 3% skimmed milk. Additionally, DAB horseradish peroxidase color development kit
95
(Tiangen Biotech, Beijing, China) was used for color development. The plate was read at 450 nm with a
96
precision microplate reader (Molecular Devices Corp., Palo Alto, CA).
TE D
M AN U
SC
RI PT
86
After 21 d, 15 sampled fish from each control and vaccinated groups were euthanized through
98
washrag soaked with 20.0 g/m3 MS-222 and dissected immediately with sterile scissors. The kidney was
99
removed, where five fish from one pool per condition were sampled for analyzing gene expression and
100
this experiment was performed in triplicate replicates. Pooled kidney tissue samples were taken from the
101
fish and immediately frozen in liquid nitrogen for subsequent RNA isolation. Total RNA was extracted
102
using TRIZOL reagent (CWBIO, Beijing, China) following manufacturer’s instruction. The isolated RNA
103
samples were diluted in RNase-free double distilled water and treated with DNase I (Takara, Dalian,
104
China) according to the manufacturer’s instructions. RNA was reverse transcribed using PrimeScript RT
105
reagent Kit (Perfect Real Time) and oligo d (T) primer (Vazyme, USA). Real-time PCR (RT-PCR) was
AC C
EP
97
ACCEPTED MANUSCRIPT performed using CFX96 Real-Time PCR Detection System (Bio-Rad, USA) and AceQ® qPCR SYBR®
107
Green Master Mix (Vazyme, USA), with 18S RNA as the endogenous control [28]. The primers of seven
108
immune-relevant genes were designed by other studies [26] and are listed in Table 1. The relative
109
quantification of gene transcription was performed as described in the previous study [6]. Each individual
110
sample was run in triplicate wells. Relative mRNA expression was calculated using 2-△△Ct method with
111
the formula, F = 2-△△Ct, △△Ct = (Ct, target gene – Ct, reference gene) – (Ct, target gene – Ct, reference gene)control [29].
112
Table 1
SC
RI PT
106
At the time point of 21 days post-vaccination, each group was randomly chosen 30 fish to transfer to
114
different tanks. Then fish were challenged by intraperitoneal injection with 30 µL culture suspension of A.
115
hydrophila (5.0 × 106 CFU/mL of fish). Mortality rates were recorded daily, and dead fish were removed
116
from the tank daily. The relative percent survival (RPS) was calculated according to Amend's method
117
[30].
TE D
M AN U
113
Data were presented as mean ± standard deviation (SD). Differences between experimental group
119
and control were generated with SPSS (version 18.0) statistical software (SPSS Inc., Chicago, IL, USA)
120
using ANOVA followed by Tukey’s post hoc tests using SPSS 18.0. A P value of <0.05 or <0.01 was
121
considered statistically significant.
AC C
122
EP
118
The amplification of the aerA gene (expected size 1332 bp) of A. hydrophila was shown in Fig. 1A.
123
When the aerA gene was cloned into the cloning vector pMD19T and eukaryotic expression plasmid
124
pEGFP, it was confirmed by restriction enzyme digestion (Fig. 1B and C) and sequence analysis (data not
125
show). Both results confirmed that recombinant plasmid was successfully constructed.
126
[Fig. 1]
ACCEPTED MANUSCRIPT To compare the humoral immune response, we evaluated the neutralizing activity of sera samples
128
obtained from vaccinated fish during 1-6 weeks post-initiation vaccination. ELISA analysis showed that
129
the antibody levels increased with the increasing doses of pEGFP-aerA or SWCNTs-pEGFP-aerA (Fig. 2).
130
The highest levels of specific antibodies were observed at 4 weeks post vaccination in 10 µg pEGFP-aerA
131
or SWCNTs-pEGFP-aerA groups. Generally, SWCNTs-pEGFP-aerA elicited higher levels of antibody
132
compared with free pEGFP-aerA at the same immunization dose. Meanwhile, no significant difference
133
was found in the fish injected with PBS and pEGFP.
134
SC
RI PT
127
M AN U
[Fig. 2]
As shown in Fig. 3, both aerA and SWCNTs-aerA in highest immunization dose induced a
136
significant enhancement of all immune-related genes (type I interferon (IFN-I), tumor necrosis factor α
137
(TNFα), C-reactive protein (CRP), interleukin 8 (IL-8), immunoglobulin M (IgM), major
138
histocompatibility complex (MHC) class I and Cluster of differentiation 8α (CD8α)) expression in the
139
kidney. Furthermore, all these genes expression were induced by 10 µg SWCNTs-pEGFP-aerA to
140
increase
141
SWCNTs-pEGFP-aerA treatments were significantly higher than that in the pEGFP-aerA groups.
143
inductions observed.
EP
than 3-fold
AC C
142
greater
TE D
135
And
the
relative
expression levels in
[Fig.3]
Grass carp were challenged by injected intramuscularly with 5.0 × 106 CFU/mL of A. hydrophila.
144
The result in Fig. 4 showed that the cumulative mortality of treatment and control groups after being
145
challenged with a lethal dose of A. hydrophila at 21 days post vaccination. For two control groups (PBS
146
and pEGFP) and two vaccinated groups (1 and 5 µg pEGFP-aerA), the mortalities were occurred at 3-day
147
after challenge and after 8-day, the cumulative mortality of two control groups was reached to 100%. For
ACCEPTED MANUSCRIPT SWCNTs-pEGFP-aerA vaccinated groups (1, 5 and 10 µg), the cumulative mortalities were reached to
149
42.7%, 30.4% and 16.3%, respectively, and comparably, a lower immune protective effects were obtained
150
in pEGFP-aerA vaccinated groups (1, 5 and 10 µg) (Table 2).
151
[Fig. 4]
152
[Table 2]
RI PT
148
In the past decade, DNA vaccine has been extensively applied for the prevention of aquaculture
154
diseases caused by different pathogens, especially infectious virus [31-33]. Compared with live,
155
attenuated vaccines, inactivated vaccines, and purified subunits of the pathogen, DNA vaccine has the
156
advantage of being inexpensive, safe, stable, and inducing both humoral and cellular immunities [34,35].
157
Immunization with antigen-encoding plasmid DNA can produce the target protein in vivo upon
158
introduction to the host, thereby eliciting powerful and long-lasting cellular and humoral immune
159
responses that is similar to that induced by natural infection with intracellular pathogens [36]. However,
160
the rapid tissue clearance and on-site degradation of DNA of conventional DNA vaccination may reduce
161
pDNA uptake and transgene expression [37,38]. To enhance the efficacy of DNA vaccines, in this study,
162
SWCNTs vaccine delivery system was used to deliver pEGFP-aerA DNA vaccine against A. hydrophila.
163
Our previous study have found that higher levels of transcription and expression of the vp7 gene of
164
GCRV could be detected in muscle tissues of grass carp 28 days post-injection in SWCNTs-pcDNA-vp7
165
treatment groups comparing with naked pcDNA-vp7 treatment groups [23]. In addition, the potency of
166
ammonium group-functionalized multi-walled carbon nanotubes (MWCNTs) could enhance the
167
transfection and expression efficiency of plasmid DNA (pEGFP-vp5) in Ctenopharyngodon idellus
168
kidney (CIK) cells [39]. SWCNTs was also found to facilitate higher pDNA uptake and gene expression
AC C
EP
TE D
M AN U
SC
153
ACCEPTED MANUSCRIPT than pDNA alone in Chinese hamster ovary cells [40]. In the challenge test, the result reflected that
170
pEGFP-aerA DNA vaccine could protect grass carp against A. hydrophila infection, with a lower
171
percentage of mortality rates in 15 days. Further, SWCNTs- pEGFP-aerA DNA vaccine showed a better
172
protection efficacy on grass carp than pEGFP-aerA, and naked plasmid vaccine did not enhance innate
173
antibacterial immunity of fish as the control group. These results were in agreement with the previous
174
findings that SWCNTs can improve the plasmid/antigen stability, and prolong the time of plasmid/antigen
175
degradation [23].
SC
RI PT
169
In the past, most research about DNA vaccines against bacterial pathogens in aquaculture have been
177
reported, and these vaccine were demonstrated to be effective against challenges of the respective
178
pathogens [41-44]. In our tests, the levels of specific antibody increased significantly and persisted up to
179
6 weeks of post immunization. It might be that the SWCNTs-pEGFP-aerA could be delivered into the fish
180
cells, and the plasmid DNA was released from the nanotubes, and thus expressed antigen. With the
181
increase of amounts of plasmid DNA released from SWCNTs, more antigens were expressed and stronger
182
immune response was induced.
EP
TE D
M AN U
176
In the present study, we compared the expressions of immune-related genes of free pEGFP-aerA and
184
SWCNTs-pEGFP-aerA DNA vaccine on grass carp via intramuscular injection immunization. The results
185
indicated that fish immunization with SWCNTs-pEGFP-aerA DNA vaccine augmented the production of
186
specific antibodies and exhibited a high level of survival rate compared with pEGFP-aerA alone. Herein,
187
consistent with the production of specific antibodies (Fig. 2), the IgM expression was increased
188
significantly in vaccinated fish kidney. It is known that IgM is a major component of the humoral immune
189
system of teleost fish, regarded as the first antibody [45,46]. Some investigators have reported that the
AC C
183
ACCEPTED MANUSCRIPT IgM expression would be intensively increase in many tissues and organs from the second week after
191
immunization and maintained almost one month [47]. Besides, IL-8, IFN-I and TNFα, an important
192
component in innate immunity and the inflammatory, were also found up-regulated by the DNA vaccine
193
treatment in this study. These genes were considered to be an important component in innate immunity
194
and antivirus response in fish [48-50], and especially TNFα is considered as an important
195
pro-inflammatory factors to induce the inflammatory response by regulating the expression of other
196
cytokines [51]. Thus, the risen gene levels may reflect the initiation of specific adaptive immune
197
responses [52]. Additionally, CRP levels were observed to increase in grass carp vaccinated with
198
pEGFP-aerA/SWCNTs-pEGFP-aerA DNA vaccines, while CRP usually served as the major acute phase
199
reactant and played an important role in the innate immune response to an inflammatory stimulus in fish
200
[53]. Since MHC I are involved in offering antigenic peptides for recognition by the TCR/CD8 complex
201
of cytotoxic T lymphocytes and CD8 molecules acts as a coreceptor and lies in its active role in activating
202
T cells [6,54,55], their up-regulation indicated that the protective effect of the DNA vaccines might be
203
due to the induction of humoral and cellular immune response.
EP
TE D
M AN U
SC
RI PT
190
Currently, it is an important consideration on safety in preparing the vaccine on fish. Even though a
205
series of researches have assessed toxicity of raw carbon nanotubes in mice, no significant effect was
206
found in cell culture experiments [56]. For fish embryos and larvae, Zhu et al. found that a series of
207
tested index were significantly changed when the concentration of SWCNTs was above 50 mg/L by bath
208
exposure [57]. However, there was no report about the toxicity of CNTs in fish by intramuscular injection,
209
and the information was lack in relative action mechanisms. Therefore, toxicity assessment on aquatic
210
animals of SWCNTs is also needed to make further studies.
AC C
204
ACCEPTED MANUSCRIPT In conclusion, our results showed that SWCNTs loaded with DNA vaccine induced a better
212
protection to juvenile grass carp against A. hydrophlia. Moreover, SWCNTs conjugated with DNA
213
vaccine provided significantly protective immunity compared with free DNA vaccine. Thereby, SWCNTs
214
may be considered as a potential efficient DNA vaccine carrier to enhance the immunological activity.
216
This work was supported by the Scientific Innovation and Achievements Transformation Fund for Northwest A&F University (XNY2013-25).
SC
215
RI PT
211
AC C
EP
TE D
M AN U
217
ACCEPTED MANUSCRIPT 218
Reference
219
[1] Plant KP, Lapatra SE. Advances in fish vaccine delivery. Dev Comp Immunol. 2011 35:1256–62.
220
[2] Huang L, Qin Y, Yan Q, Lin G, Huang L, Huang B, Huang W. MinD plays an important role in Aeromonas hydrophila adherence to Anguilla japonica mucus. Gene. 2015 565:275–81.
RI PT
221
[3] Sahoo P, Das Mahapatra K, Saha J, Barat A, Sahoo M, Mohanty B, Sahoo M, Mohanty BR, Gjerde B,
223
Odegård J, Rye M, Salte R. Family association between immune parameters and resistance to
224
Aeromonas hydrophila infection in the Indian major carp, Labeo rohita, Fish Shellfish Immunol. 2008
225
25:163–9.
M AN U
SC
222
226
[4] Mu X, Pridgeon JW, Klesius PH. Comparative transcriptional analysis reveals distinct expression
227
patterns of channel catfish genes after the first infection and re-infection with Aeromonas hydrophila,
228
Fish Shellfish Immunol. 2013 35:1566–76.
230
[5] Kregiel D, Niedzielska K. Effect of plasma processing and organosilane modifications of polyethylene
TE D
229
on Aeromonas hydrophila biofilm formation. BioMed Res Int. 2014 (8 pages). [6] Liu L, Gong YX, Zhu B, Liu GL, Wang GX, Ling F. Effect of a new recombinant Aeromonas
232
hydrophila vaccine on the grass carp intestinal microbiota and correlations with immunological
233
responses. Fish Shellfish Immunol. 2015 45:175–83.
235 236 237 238
AC C
234
EP
231
[7] Cao H, He S, Wang H, Hou S, Lu L, Yang X. Bdellovibrios, potential biocontrol bacteria against pathogenic Aeromonas hydrophila. Vet Microbiol. 2012 154:413–8. [8] Cabello FC. Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environ Microbiol. 2006 8:1137–44. [9] Fang HM, Ge R, Sin YM. Cloning, characterization and expression of Aeromonas hydrophila major
ACCEPTED MANUSCRIPT 239 240 241
adhesin. Fish Shellfish Immunol. 2004 16:645–58. [10] Khushiramani R, Girisha SK, Karunasagar I, Karunasagar I. Protective efficacy of recombinant OmpTS protein of Aeromonas hydrophila in Indian major carp. Vaccine. 2007 25:1157–8. [11] Guan R, Xiong J, Huang W, Guo S. Enhancement of protective immunity in European eel (Anguilla
243
anguilla) against Aeromonas hydrophila and Aeromonas sobria by a recombinant Aeromonas outer
244
membrane protein. Acta Biochim Biophys Sin. 2011 43:79–88.
247 248
SC
246
[12] Poobalane S, Thompson KD, Ardó L, Verjan N, Han HJ, Jeney G, et al. Production and efficacy of an Aeromonas hydrophila recombinant S-layer protein vaccine for fish. Vaccine. 2010 28:3540–7.
M AN U
245
RI PT
242
[13] Yeh HY, Klesius PH. Over-expression, purification and immune responses to Aeromonas hydrophila AL09-73 flagellar proteins. Fish Shellfish Immunol. 2011 31:1278–83.
[14] Khushiramani RM, Maiti B, Shekar M, Girisha SK, Akash N, Deepanjali A, et al. Recombinant
250
Aeromonas hydrophila outer membrane protein 48 (Omp48) induces a protective immune response
251
against Aeromonas hydrophila and Edwardsiella tarda. Res Microbiol. 2012 163:286–91.
253
[15] Evensen Ø, Leong JAC. DNA vaccines against viral diseases of farmed fish. Fish Shellfish Immunol.
EP
252
TE D
249
2013 6:1751–8.
[16] Nakanishi T, Kiryu I, Ototake M. Development of a new vaccine delivery method for fish:
255
percutaneous administration by immersion with application of a multiple puncture instrument.
256
Vaccine. 2002 20:3764–9.
257 258 259
AC C
254
[17] Garver K, Conway C, Elliott D, Kurath G. Analysis of DNA-vaccinated fish reveals viral antigen in muscle, kidney and thymus, and transient histopathologic changes. J Mar Biotechnol. 2005 7:540–53. [18] Bianco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalised carbon
ACCEPTED MANUSCRIPT 260
nanotubes. Chem Commun–Camb. 2005 7:571–7. [19] Yandar N, Pastorin G, Prato M, Bianco A, Patarroyo ME, Lozano JM. Immunological profile of a
262
Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium
263
berghei mouse model. Vaccine. 2008 26:5864–73.
RI PT
261
[20] Parra J, Abad-Somovilla A, Mercader JV, Taton TA, Abad-Fuentes A. Carbon nanotube-protein
265
carriers enhance size-dependent self-adjuvant antibody response to haptens. J Control Release. 2013
266
170:242–51.
SC
264
[21] Villa CH, Dao T, Ahearn I, Fehrenbacher N, Casey E, Rey DA, et al. Single-walled carbon nanotubes
268
deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens.
269
ACS Nano. 2011 5:5300–11.
271
[22] Prato M, Kostarelos K, Bianco A. Functionalized carbon nanotubes in drug design and discovery. Acc Chem Res. 2008 41:60–8.
TE D
270
M AN U
267
[23] Zhu B, Liu GL, Gong YX, Ling F, Wang GX. Protective immunity of grass carp immunized with
273
DNA vaccine encoding the vp7 gene of grass carp reovirus using carbon nanotubes as a carrier
274
molecule. Fish Shellfish Immunol. 2015 42:325–34.
EP
272
[24] Gong YX, Zhu B, Liu GL, Liu L, Ling F, Wang GX, Xu XG. Single-walled carbon nanotubes as
276
delivery vehicles enhance the immunoprotective effects of a recombinant vaccine against Aeromonas
277
hydrophila. Fish Shellfish Immunol. 2014 42:213–20.
AC C
275
278
[25] Vázquez-Juárez RC, Barrera-Saldaña HA, Hernández-Saavedra NY, Gómez-Chiarri M, Ascencio F.
279
Molecular cloning, sequencing and characterization of omp48, the gene encoding for an antigenic
280
outer membrane protein from Aeromonas veronii. J Appl Microbiol. 2003 94:908–18.
ACCEPTED MANUSCRIPT 281
[26] Zhu B, Liu GL, Gong YX, Ling F, Song LS, Wang GX. Single-walled carbon nanotubes as candidate
282
recombinant subunit vaccine carrier for immunization of grass carp against grass carp reovirus. Fish
283
Shellfish Immunol. 2014 279–93.
285
[27] Ding WD, Cao LP, Cao ZM. Purification of serum IgM from grass carp (Ctenopharyngodon idellus)
RI PT
284
and preparation of rabbit sera anti-IgM. Acta Hydrobiol Sin. 2010 34:164–9.
[28] Su J, Zhang R, Dong J, Yang C. Evaluation of internal control genes for qRT-PCR normalization in
287
tissues and cell culture for antiviral studies of grass carp (Ctenopharyngodon idella). Fish Shellfish
288
Immunol. 2011 30:830–5.
291 292
M AN U
290
[29] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−∆∆CT method. Methods. 2001 25:402–8.
[30] Amend DF. Potency testing of fish vaccines. International symposium on fish biologics: serodiagnostics and vaccines. Dev Biol Stand. 1981 49:447–54.
TE D
289
SC
286
[31] Garver KA, Lapatra SE, Gael K. Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA
294
vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon. Dis Aquat Organ. 2005
295
64:13–22.
EP
293
[32] Lorenzen N, Lorenzen E, Einer-Jensen K, Heppell J, Wu T, Davis H. Protective immunity to VHS in
297
rainbow trout (Oncorhynchus mykiss, Walbaum) following DNA vaccination. Fish Shellfish Immunol.
298
1998 8:261–70.
AC C
296
299
[33] Takano T, Iwahori A, Hirono I, Aoki T. Development of a DNA vaccine against hirame rhabdovirus
300
and analysis of the expression of immune-related genes after vaccination. Fish Shellfish Immunol.
301
2004 17:367–74.
ACCEPTED MANUSCRIPT
304 305 306 307
2000 43:29–43. [35] Tonheim TC, Bogwald J, Dalmo RA. What happens to the DNA vaccine in fish? A review of current knowledge. Fish Shellfish Immunol. 2008 25:1–18.
RI PT
303
[34] Heppell J, Davis HL. Application of DNA vaccine technology to aquaculture. Adv Drug Deliv Rev.
[36] Chen ZY, Lei XY, Zhang QY. The antiviral defense mechanisms in mandarin fish induced by DNA vaccination against a rhabdovirus. Vet Microbiol. 2012 157:264–75.
SC
302
[37] Hølvold LB, Fredriksen BN, Bøgwald J, Dalmo RA. Transgene and immune gene expression
309
following intramuscular injection of Atlantic salmon (Salmo salar L.) with DNA-releasing PLGA
310
nano- and microparticles. Fish Shellfish Immunol. 2013 35:890–9.
M AN U
308
[38] Tom Christian T, Roy Ambli D, Jarl BG, Tore S. Specific uptake of plasmid DNA without reporter
312
gene expression in Atlantic salmon (Salmo salar L.) kidney after intramuscular administration. Fish
313
Shellfish Immunol. 2008 24:90–101.
TE D
311
[39] Liu GL, Wang Y, Hu Y, Yu X, Zhu B, Wang GX. Functionalized multi-wall carbon nanotubes
315
enhance transfection and expression efficiency of plasmid DNA in fish cells. Int J Mol Sci. 2016 17:
316
doi, 10.3390/ijms17030335.
318
[40] Davide P, Ravi S, David MC, Mathieu E, Jean-Paul B, Maurizio P, et al. Functionalized carbon
AC C
317
EP
314
nanotubes for plasmid DNA gene delivery. Angew Chem Int Ed. 2004 43:5242–6.
319
[41] Kumar SR, Parameswaran V, Ahmed VP, Musthaq SS, Hameed AS. Protective efficiency of DNA
320
vaccination in Asian seabass (Lates calcarifer) against Vibrio anguillarum. Fish Shellfish Immunol.
321
2007 23:316–26.
322
[42] Pasnik DJ, Smith SA. Immunogenic and protective effects of a DNA vaccine for Mycobacterium
ACCEPTED MANUSCRIPT 323
marinum in fish. Vet Immun Immunopathol. 2005 103:195–206. [43] Pasnik DJ, Smith SA. Immune and histopathologic responses of DNA-vaccinated hybrid striped bass
325
Morone saxatilis × M. chrysops after acute Mycobacterium marinum infection. Dis Aquat Organ.
326
2006 73:33–41.
RI PT
324
[44] Rajesh Kumar S, Ishaq Ahmed VP, Parameswaran V, Sudhakaran R, Sarath Babu V, Sahul Hameed
328
AS. Potential use of chitosan nanoparticles for oral delivery of DNA vaccine in Asian sea bass (Lates
329
calcarifer) to protect from Vibrio (Listonella) anguillarum. Fish Shellfish Immunol. 2008 25:47–56.
330
[45] Lorenzen N, Lapatra SE. Immunity to rhabdoviruses in rainbow trout: the antibody response. Fish
332 333
Shellfish Immunol. 1999 9:345–60.
M AN U
331
SC
327
[46] Reddy PS, Corley RB. The contribution of ER quality control to the biologic functions of secretory IgM. Immunol Today. 1999 20:582–8.
[47] Cui M, Zhang Q, Yao Z, Zhang Z, Zhang H, Wang Y. Immunoglobulin M gene expression analysis
335
of orange-spotted grouper, Epinephelus coioides, following heat shock and Vibrio alginolyticus
336
challenge. Fish Shellfish Immunol. 2010 29:1060–5.
339 340 341 342 343
EP
338
[48] Secombes C, Wang T, Hong S, Peddie S, Crampe M, Laing K, et al. Cytokines and innate immunity of fish. Dev Comp Immunol. 2001 25:713–23.
AC C
337
TE D
334
[49] Colonna M, Krug A, Cella M. Interferon-producing cells: on the front line in immune responses against pathogens. Curr Opin Immunol. 2002 14:373–9. [50] Baldwin ET, Weber IT, Charles RS, Xuan J, Appella E, Yamanda M, et al. Crystal structure of interleukin-8: symbiosis of NMR and crystallography. Proc Natl Acad Sci. 1991 88:502–6. [51] Dan XM, Zhang TW, Li YW, Li AX. Immune responses and immune-related gene expression profile
ACCEPTED MANUSCRIPT 344
in orange-spotted grouper after immunization with Cryptocaryon irritans vaccine. Fish Shellfish
345
Immunol. 2013 34:885–91.
347
[52] Pashine A, Valiante NM, Ulmer JB. Targeting the innate immune response with improved vaccine adjuvants. Nat Med. 2005 11:S63–S8.
RI PT
346
[53] Maccarthy E, Burns I, Irnazarow I, Polwart A, Tj, Shrive A, Hoole D. Serum CRP-like protein
349
profile in common carp Cyprinus carpio challenged with Aeromonas hydrophila and Escherichia coli
350
lipopolysaccharide. Dev Comp Immunol. 2008 32:1281–9.
355 356 357 358 359
M AN U
354
[55] Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 1994 76:287–99.
[56] Liu Z, Tabakman S, Welsher K, Dai H. Carbon nanotubes in biology and medicine: in vitro and in
TE D
353
Immunol. 19897:601–24.
vivo detection, imaging and drug delivery. Nano Res. 2009 2:85–120. [57] Zhu B, Liu G L, Ling F, Song LS, Wang GX. Development toxicity of functionalized single-walled
EP
352
[54] Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev
carbon nanotubes on rare minnow embryos and larvae. Nanotoxicology, 2014 9:1–12.
AC C
351
SC
348
ACCEPTED MANUSCRIPT Figure captions
361
Fig. 1. Analysis of aerA expression. (A) RT-PCR amplification of aerA: lane M, DNA marker; lane 1,
362
aerA. (B) analysis of recombinant plasmid: lane M, DNA marker; lane 1, double enzymes digested
363
pMD19T-aerA with Xho I and BamH I; lane 2, pMD19T-aerA. (C) analysis of recombinant plasmid: lane
364
M, DNA marker; lane 1, pEGFP-aerA; lane 2, double enzymes digested pEGFP-aerA with Xho I and
365
BamH I.
366
Fig. 2. Specific antibody levels of fish vaccinated with DNA vaccine were determined by ELISA. Data
367
are means for three assays and presented as the means ± SE. **P < 0.01; *P < 0.05.
368
Fig. 3. Real-time PCR analysis of the expression of immune-related genes in fish vaccinated with
369
different vaccine formulations after 21 d. (A) IL-8; (B) IFN-I; (C) TNFa; (D) CRP; (E) MHC-I; (F) IgM;
370
(G) CD8α. Data are means for three assays and presented as the means ± SE. **P < 0.01; *P < 0.05.
371
Fig. 4. Cumulative mortalities of vaccinated fish. The accumulated mortalities were calculated at the end
372
of the monitored period.
AC C
EP
TE D
M AN U
SC
RI PT
360
ACCEPTED MANUSCRIPT Table 1 Sequences of primer pairs used for the analysis of mRNA expression by qRT-PCR.
Product size (bp)
GenBank accession no.
Forward
ATTTCCGACACGGAGAGG
90
EU047719
Reverse
CATGGGTTTAGGATACGCTC
Forward
GGTGAAGTTTCTTGCCCTGACCTTAG
173
AB196166
Reverse
CCTTATGTGATGGCTGGTATCGGG
TNF-α
Forward
TGTGCCGCCGCTGTCTGCTTCACGCT
291
EU047718
Reverse
GATGAGGAAAGACACCTGGCTGTAGA
CRP
Forward
CTGCCTCCGCTCTCCATCTT
300
FJ547474
Reverse
TCCCTTTGGCACATACGGTTCCTGA
IL-8
Forward
AGGTCTGGGTGTAGATCCACGCTG
Reverse
TTAGTGTGAAAACTAACATGATCTCT
IgM
Forward
GCTGAGGCATCGGAGGCACAT
MHC-I
Reverse
TTGGGTCTCGCACCATTTTCTC
Forward
CCTGGCAGAAAAATGGACAAG
Reverse
CCAACAACACCAATGACAATC
Forward
GAGTCTCTGCACGGATCTAT
Reverse
GTGTAGTGTTCCGAATTTAAGT
AC C
EP
TE D
CD8α
SC
IGF-I
137
EU047717
170
DQ417927
M AN U
18S
RI PT
Primer sequences (from 5' to 3')
Genes
271
AY391782
172
GQ355586
ACCEPTED MANUSCRIPT Table 2 Corresponding RPS values of vaccinated and control fish. Cumulative percentage mortality (%) and calculated relative percentage survival (RPS) following challenge with A. hydrophila in experimental
Fish injected with
Cumulative mortality (21 d)
PBS
100.0%
pEGFP 10 µg
100.0%
pEGFP-aerA 1 µg
92.1%
pEGFP-aerA 5 µg
70.7%
pEGFP-aerA 10 µg
54.9%
SWCNTs-pEGFP-aerA 1 µg
42.7%
EP AC C
—
SC
7.9%
29.3%
45.1%
57.3%
30.4%
69.6%
16.3%
83.7%
TE D
SWCNTs-pEGFP-aerA 10 µg
RPS (21 d)
—
M AN U
SWCNTs-pEGFP-aerA 5 µg
RI PT
groups of DNA vaccinated fish by intramuscular injection.
ACCEPTED MANUSCRIPT
M
1
B
M
1
2
M
1
2
AC C
EP
TE D
C
M AN U
SC
RI PT
A
Fig. 1.
ACCEPTED MANUSCRIPT
0.7
**
PBS
**
**
** **
**
0.5 0.4
**
**
0.3
** **
**** **
** **
**
** ** ** **
**
**
** **
**
**
** **
pEGFP-aerA 1 µg pEGFP-aerA 5 µg pEGFP-aerA 10 µg SWCNTs-pEGFP-aerA 1 µg
*
*
SWCNTs-pEGFP-aerA 5 µg
0.2
RI PT
Absorbance (OD450)
**
0.6
SWCNTs-pEGFP-aerA 10 µg
0.1
pEGFP
0 1
2
3
4
6
SC
Weeks post-vaccination
5
AC C
EP
TE D
M AN U
Fig. 2.
ACCEPTED MANUSCRIPT A
4
pEGFP-aerA
IL-8
**
Fold change
SWCNTs-pEGFP-aerA
3
** *
2
RI PT
1 0 PBS
pEGFP
*
*
1
5
10
Fold change
4
pEGFP-aerA
IFN-I
SWCNTs-pEGFP-aerA
3
**
2
TE D pEGFP
EP
PBS
pEGFP-aerA
AC C
5 4
**
*
0
Fold change
**
**
1
C
M AN U
5
B
SC
Injected dose (µg)
1
5
10
Injected dose (µg)
TNFα
**
**
SWCNTs-pEGFP-aerA
**
3
**
*
2 1 0
PBS
pEGFP
1
5 Injected dose (µg)
10
ACCEPTED MANUSCRIPT 6
Fold change
5
pEGFP-aerA
CRP
**
SWCNTs-pEGFP-aerA
**
4 3
**
*
2
RI PT
D
1 0 PBS
pEGFP
1
5
10
pEGFP-aerA
MHC-I
Fold change
SWCNTs-pEGFP-aerA
6 4
**
**
12
pEGFP
EP
PBS
TE D
0
AC C
pEGFP-aerA
1
**
**
**
2
F
M AN U
8
E
SC
Injected dose (µg)
5
10
Injected dose (µg)
IgM
**
Fold change
SWCNTs-pEGFP-aerA
9
**
6
**
** **
3 0 PBS
pEGFP
1
5 Injected dose (µg)
10
ACCEPTED MANUSCRIPT 5
Fold change
4
pEGFP-aerA
CD8α
**
SWCNTs-pEGFP-aerA
**
3
**
**
2 1 0 PBS
pEGFP
1
RI PT
G
5
SC
Injected dose (µg)
AC C
EP
TE D
M AN U
Fig. 3.
10
100 90 80 70 60 50 40 30 20 10 0
PBS pEGFP 10 µg pEGFP-ae rA 1 µg pEGFP-ae rA 5 µg pEGFP-ae rA 10 µg SWC NTs-pEGFP-ae rA 1 µg SWC NTs-pEGFP-ae rA 5 µg SWC NTs-pEGFP-ae rA 10 µg
3
6
9
12
Days after challenge
18
21
AC C
EP
TE D
M AN U
SC
Fig. 4.
15
RI PT
Cumulative mortality (%)aaa
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT Highlights: 1. SWCNTs can be used as carriers for DNA vaccine. 2. SWCNTs-DNA vaccine enhanced the immunological activity.
AC C
EP
TE D
M AN U
SC
RI PT
3. SWCNTs-DNA vaccine induced a better protection to grass carp against A. hydrophlia.